Unknown

Dataset Information

Brigatinib for anaplastic lymphoma kinase-tyrosine kinase inhibitor naive anaplastic lymphoma kinase-positive advanced non-small cell lung cancer: an effective but still broken option.


ABSTRACT:

SUBMITTER: Ricciuti B 

PROVIDER: S-EPMC6987338 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature